The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
COVID-19 and Cardiovascular Disease: From Bench to Bedside
Open accessAbstract
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential consequences on the cardiovascular health of millions of people who survive infection worldwide. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the etiologic agent of COVID-19, can infect the heart, vascular tissues, and circulating cells through ACE2 (angiotensin-converting enzyme 2), the host cell receptor for the viral spike protein. Acute cardiac injury is a common extrapulmonary manifestation of COVID-19 with potential chronic consequences. This update provides a review of the clinical manifestations of cardiovascular involvement, potential direct SARS-CoV-2 and indirect immune response mechanisms impacting the cardiovascular system, and implications for the management of patients after recovery from acute COVID-19 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–206 of 206
Schmidt, R., Morrell, C. N., Ling, F. S. K., Simlote, P., Fernandez, G., Rich, D. Q., Adler, D., Gervase, J., & Cameron, S. J. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.006 · Cited by 29
Self-citationDetection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
Dragonetti, D., Guarini, G., & Pizzuti, M. (2020) · Blood transfusion · doi:10.2450/2020.0164-20 · Cited by 29
Scannell, C. A., Oronce, C. I. A., & Tsugawa, Y. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06083-8 · Cited by 28
Network determinants of cardiovascular calcification and repositioned drug treatments
Song, J.-S., Wang, R., Leopold, J. A., & Loscalzo, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001062r · Cited by 24
Self-citationAntibody-Based Immunotherapeutic Strategies for COVID-19
Hussen, J., Kandeel, M. K., Hemida, M. G., & Al-Mubarak, A. I. A. (2020) · Pathogens · doi:10.3390/pathogens9110917 · Cited by 18
An overview of potential therapeutic agents to treat COVID-19
Dong, X., Tian, Z., Shen, C., & Zhao, C. (2020) · BioScience Trends · doi:10.5582/bst.2020.03345 · Cited by 6
Cited by
Long-term cardiovascular outcomes of COVID-19
Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-01689-3 · Cited by 2,029
Montani, D., Savale, L., Noel, N., Meyrignac, O., Colle, R., Gasnier, M., Corruble, E., Beurnier, A., Jutant, E.-M., Pham, T., et al. (2022) · European Respiratory Review · doi:10.1183/16000617.0185-2021 · Cited by 263
Čiháková, D., Shi, Y., Adhikari, B., Bandettini, W. P., Cunningham, M. W., Danthi, N., Friedrich, M. G., Liu, P., Longacre, L. S., Mann, D. L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195721 · Cited by 13
Metadata
- Authors
- Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T., Harding, C. V., Kwon, D. H., Singh, T., Tilton, J. C., Tsai, E. J., Tucker, N. R., Barnard, J., & Loscalzo, J.
- Venue
- Circulation Research
- Published
- 2021-04-16
- Volume
- 128
- Issue
- 8
- Pages
- 1214-1236
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3153551701
- Cited by
- 373
- References
- 206
- FWCI
- 24.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.